An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer

Clinical trial NCT01677455 · COMPLETED

Trial details

NCT number: NCT01677455
Sponsor: Synta Pharmaceuticals Corp.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer HER-2 Positive Breast Cancer Triple Negative Breast Cancer ER/Progressive Response (PR) + Refractory to Prior Hormonal Treatment

Start date: 2012-07-01
Primary completion: 2015-04-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.